Colchicum species, which have been widely used as a medication for years, still remain important in treatment of Familial Mediterranean Fever, gout and Behcet's Disease. In the present work, alkaloids, phenolic compounds and cytotoxic activities from different parts of two Colchicum species, namely C. chalcedonicum and C. micranthum were investigated for the first time. From different parts of two species, alkaloids were isolated and colchicine concentrations were also determined by HPLC. The methanol extracts were investigated for their cytotoxic activity against the A549 cell line using the MTT and LDH methods. Additionally, the phenolic compounds of each extract were investigated by LC-MS/MS. Six alkaloids, namely colchicine, colchifoline, 2-demethylcolchicine, demecolcine, 4-hydroxycolchicine and N-deacetyl-N-formylcolchicine were isolated from different parts of two species. The autumn corm of C. micranthum possessed the highest amount of colchicine among all extracts. All extracts showed high cytotoxicity, while the highest toxicity was determined in the seed extract. According to the LC-MS/MS analysis, 19 phenolic compounds were shown to be present. This is the first study which highlights that the seeds of C. chalcedonicum and autumn corms of C. micranthum could be valuable for the pharmaceutical industry to obtain colchicine and other tropolone alkaloids.
Turkey is one of the richest regions for the number of Colchicum species. The genus is represented by 100 species all around the world and 50 grow in Turkey [1] . Alkaloids of the Colchicum species have been investigated by many researchers [2] [3] [4] [5] . Tropolone alkaloid content, and in particular the major alkaloid colchicine, have provided medicinal significance from past to present [6] . Several studies demonstrated that colchicine possesses antitumor and anti-inflammatory activities [7] [8] [9] . Colchicine and its analogues are used clinically for the treatment of several disorders such as FMF (Familial Mediterranean Fever), gout, amyloidosis and Behcet's Disease [10] [11] . However, the narrow therapeutic index of this alkaloid limits its use in therapy. Demecolcine, the other major alkaloid, possesses low toxicity and has been used in treatment, particularly for myeloid leukemia and Hodgkin's syndrome [6] .
The distribution of tropolone alkaloids in the plant kingdom is limited. They are sensitive compounds, generally affected by light and high temperature and decompose to inactive lumi derivatives [12] . An economic and efficient chemical synthesis method for colchicine and its derivatives has not been found to date. C. autumnale, which is used for the isolation of colchicine and demecolcine in the pharmaceutical industry, does not grow in Turkey. The presence of a wide variety of Colchicum species in Turkey has driven researchers to find new sources of colchicinerich species. Studies on several Colchicum species of Turkish origin revealed the existence of colchicine-rich species and prompted us to continue looking for further colchine-abundant producers [13] .
In the present work, C. micranthum (endemic to Turkey) and C. chalcedonicum were collected at different growing stages and evaluated for their chemical composition and biological activities by analyzing their aerial and underground parts separately. The extract yield percentage of each parts and dry weight of two Colchicum species are given in Table 1 .
Colchicine (1), colchifoline (2), 2-demethylcolchicine (3), Ndeacetyl-N-formylcolchicine (4) were isolated from C. micranthum while colchicine (1), colchifoline (2), 2-demethylcolchicine (3), Ndeacetyl-N-formylcolchicine (4), 4-hydroxycolchicine (5), demecolcine (6) were isolated from C. chalcedonicum and their structures were elucidated by 1 H NMR and ESI/MS methods and comparison with reference physical data [12, 14] . The isolated alkaloids of different parts from two species are given in Table 2 . main alkaloids in all plant parts studied. Demecolcine, an another significant alkaloid in Colchicum species, was found only in the seed extracts of C. chalcedonicum. Besides, 4-hydroxycolchicine was isolated from the flowers which is a rare compound in the tropolone alkaloid group.
Colchicine amounts in the methanol extracts from each part of the plants during different growth stages were examined by HPLC. The results of the HPLC analyses are summarized in Table 3 . Additionally, the HPLC method was validated according to the experimental results of colchicine: linear range (0.02-0.0015 mg/ml); recovery (99.74±4.94 %); LOD (0.0007 mg/ml); LOQ (0.0023 mg/ml) and RSD (5.91 %). As one would expect, there are differences in colchicine concentrations among different plant parts of the species. Among the extracts of different parts from C. micranthum, the autumn corms contained the highest amount of colchicine (0.183 ± 0.021 %). Additionally, when comparing the amounts of colchicine in the two species, the highest colchicine content was found in the autumn corm extracts of C. micranthum. The corms of both species possessed higher colchicine content than the flower parts. According to previous studies, the colchicine level was found to be in the range of 0.039 % to 0.3 % in an Anatolian Colchicum species [15a] .
The corm extracts of C. micranthum contained a moderate level of colchicine while C. chalcedonicum possessed a low amount. Previous studies demonstrated that the chemical composition and colchicine concentrations of Colchicum species showed variety in different plant parts and varies during the autumn and spring season. Our results confirmed the presence of significant alkaloid colchicine with different concentrations in the different parts in two species. The content of the phenolic compounds of each methanol extract was also studied by LC/MS-MS and 19 phenolic compounds were identified. The results are given in Table 4 . LC chromatogram of C. micranthum autumn corm is shown in Figure 2 . Luteolin and caffeic acid were determined by comparing retention time and mass spectra of standards. Other compounds were tentatively identified by comparison to the retention times and mass fragmentation pattern with references. -at m/z 593 and fragmented giving several product ions at m/z 473 (-120 amu), 353 (-240 amu) due to the characteristic 120 amu losses of C-glucosides from the deprotonated molecular ion. Such losses are indicative of two sugar units so the aglycone of peak 3 must be apigenin at m/z 269. Based on this data peak 3 was identified as apigenin C-hexoside C-hexoside. Peak 4 showed an [M−H] -molecular ion peak at m/z 401 and a base peak ion at m/z 269 (apigenin) due to a loss of a pentose residue. Further product ions were observed at m/z 161 and m/z 113. According to these results peak 4 was identified as apigenin pentoside. Peak 5 presented a deprotonated molecular ion at m/z 463 and a base peak ion at m/z 301 due to the loss of a glucose moiety. A further fragment for the aglycone was also observed at m/z 257 which indicated that the aglycone was most probably quercetin or an ellagic acid. Because some of the aglycons fragmentation was absent (for example m/z 179 and 161 for quercetin and m/z 229 for ellagic acid), we were unable to unequivocably identify the compound as quercetin/elagic acid glucoside. So peak 5 was proposed as a similar unknown glucoside. The peak 7 showed a molecular ion peak at m/z 179 and a product ion at m/z 135 which was characteristic for caffeic acid. Caffeic acid has previously been identified in C. baytopiorum [13b]. This peak was confirmed with standard caffeic acid. Peak 19 was identified as luteolin which was previously determined in Colchicum species several times [13b,15c]. This spectrum was also confirmed by using a luteolin standard. Peak 6 was determined as a diglucoside of luteolin due to the loss of two glucose moieties (162 + 162) from the molecular ion peak at m/z 609. Similar identification was achieved for peak 8 which showed a deprotonated molecular ion peak at m/ z 579 and a product ion at m/z 447 (-132 / apiose) and luteolin ion as an aglycon at m/z 285 (-132 + -162). Peak 8 was identified as luteolin apiosylglucoside. Peak 12 was identified as methyl ether derivative of peak 8 (diosmetin or chrysoeriol apiosyl-glucoside). The methanol extracts were tested for general toxicity against the A549 (human lung adenocarcinoma) cell line. The IC 50 values of the extracts are given in Table 5 . All extracts were found to have moderate bioactivity but the seed extract showed high toxicity against the A549 cell line. According to this study, these two Colchicum species, which grow in Istanbul, may have potential as a source of colchinoids. Further studies are needed to be conducted on other Colchicum species for pharmaceutical industry sources of tropolone alkaloids. . All plant parts were separated and dried at room temparature, except for the corms which were separated and sliced then left to dry in a drying oven at 60°C.
Experimental

Extraction and isolation:
All dried plant materials (corms and flowers) were extracted separately with methanol using a Soxhlet apparatus. The seeds were extracted firstly with petroleum ether to defat and then with methanol using a Soxhlet apparatus. The solvents were evaporated in a rotavapor at 40 0 C. The obtained methanol extracts were dissolved in water using an ultrasonic bath, and then filtered. The filtrate was made acidic with 3% H 2 SO 4 (pH 3-4) and extracted with chloroform. The chloroform extracts were combined and dried over anhydrous Na 2 SO 4 , filtered to yield neutral-phenolic extract (extract A). During the study, all extracts were protected from direct light to reduce compound degradation.
Preliminary separation of the alkaloids of the autumn corms (extract A) from C. micranthum was achieved by SPE with a normal phase cartridge, eluting with a gradient elution of hexane:chloroform: methanol. Similar fractions were combined and monitored with Dragendorff and Carr-Price reagents. Fractions 12-13 (100 mg) were purified by preparative HPLC (Waters 2555 Quaternary Gradient Module) using Phenomenex C18 column (5 µm, 21.20 mm x 250 mm) with an isocratic mobile phase system (acetonitrile:water, 25:75) with a 10 mL/min flow rate, monitoring at 254 nm and injecting 100 mg of fraction. Compounds 1 (8,5 mg), 2 (1.5 mg) and 3 (5mg) were isolated and monitored by TLC. The alkaloids of the flowers from C. micranthum (extract A) were subjected to an SPE normal phase cartridge followed by preparative TLC. The combined fractions 12-14 (50 mg) were purified with preparative-TLC on silica gel using a chloroform:acetone: diethylamine (5:4:1) solvent system to yield compound 1 (3.5 mg). Fractions 15-16 (170 mg) were purified by preparative-TLC on silica gel using a chloroform:acetone:diethylamine:methanol (11:8:2:3) solvent system to yield compounds 2 (1.5 mg) and 4 (1.4 mg).
The alkaloids of C. chalcedonicum were isolated in three different parts. The seed (A) extract (200 mg) was purified by preparative-TLC on silica gel using toluene:ethylacetate:diethyamine:methanol (50:40:10:8) as solvent system. Further purification of the mixture used TLC on silica gel using a chloroform:acetone:diethylamine (5:4:1) solvent system. Compounds 1 (5,5 mg), 2 (5 mg), 4 (3 mg) and 6 (3 mg) were isolated and monitored by TLC. The separation of the autumn corm (A) extract was achieved by SPE with a normal phase cartridge, eluting with a gradient elution of hexane:chloroform:methanol. Similar fractions were combined and then again monitored by TLC with Dragendorff and Carr-Price reagents. The separation of fractions 11-13 (165 mg) was achieved by preparative-TLC on silica gel with chloroform:acetone: diethylamine:methanol (11:8:2:3) to yield compounds 1 ( 3.8 mg), 2 (3.8 mg) and 3 (1.8 mg). The flower extract was separated by silica gel column chromatography eluting with chloroform and methanol. Fractions 44-45 were combined and purified by preparative-TLC on silica gel using chloroform:acetone:diethylamine (5:4:1) to yield compound 1 (2.2 mg). Fractions 47-50 were combined and purified with preparative-TLC on silica gel with chloroform:acetone: diethylamine:methanol (11:8:2:3) to yield compounds 2 (1.6 mg) and 5 (1.2 mg). All of the pure alkaloids were eluted with chloroform:methanol (8:2).
Quantification of colchicine by HPLC:
Colchicine concentrations in the methanol extracts were determined using HPLC. The HPLC analysis was performed on an Agilent 1200 series instrument. The analytical HPLC column was Sepax C18 column of 5 µm particle size and 4.6mm x 250mm dimensions and the column was used with mobile phase acetonitrile (solvent A) and 1 % acetic acid in water (solvent B). The column was run with gradient elution at 1 mL/min (0-25 min 10-60% A, 25-30 min 60% B, 30-35 min 60-10 % and 35-40 min 10% A). Detection was carried out with a UV/VIS detector. The methods described by Alali et al., were adopted with some modifications [15d] . A reference standard of colchicine was prepared from the USP. The flow rate was set to 1 mL/min; injection volume and column temperature were adjusted to 10 µL and 40°C, respectively. The detection was performed at 352 nm. The HPLC method was validated based on the experimental results; LOD, LOQ, RSD and recovery. The colchicine concentration in each extract was calculated by the following regression equation y= 69716x -24,23 with good linearity (r2 = 0.9992).
Sample preparation:
The six point calibration curve for colchicine was prepared with the external standard solution within the concentration range of 0.02-0.0015 mg/mL, in methanol. The dried methanol extracts were redissolved in methanol. The methanol extracts were at a concentration of 5 mg/mL concentration for the corm and flower samples and at a 2 mg/mL concentration for seed samples. All samples and solvents were filtered using a 0.45 µm membrane filter before HPLC analysis. The analysis were performed in triplicate for each extract. 
LC-MS/MS analysis of extracts: LC-MS
Cytotoxicity activities of extracts:
The MTT and LDH tests were used to evaluate the cytotoxic potential of the methanol extracts that were prepared from different plant parts against the A549 cell line. IC 50 value of each extract were calculated according to cytotoxicity index. The A549 cell line was obtained from the American Type Culture Collection (ATCC, USA). Five concentrations of each extract and colchicine was prepared (500, 100, 50, 10, 1 μg/mL). After cell adhesion, the solution was removed and new cell culture solution with various concentrations of the methanol extracts was added. After incubation with the extracts for 24 h, the cytotoxicity of each extract was determined using the MTT and LDH assays. All assay were repeated three times for each concentration of all methanol extracts. The cytotoxic effects of the extracts were studied by using in part Plumb's method [16] . In brief, after 24 h incubation with the extracts, an MTT solution (50 µL) (2 mg/mL in PBS) was added to each well. The cells were incubated at 37°C for 4 h.
Following incubation, the supernatant containing the MTT was removed and then 200 µL of DMSO and 25 μL of Sorensen's glycine buffer were added. The absorbance (A) of each well was then read at 570 nm (against the reference wavelength of 670 nm) using an ELISA reader. A cytotoxicity index of each extract was calculated using the formula below:
Cytotoxicity Index (%) = 1 -[(Atreated wells/A control cells] x 100 A Biovision (K311-400) cytotoxicity detection kit was used for the LDH assay. Folllowing 24 h treatment with extracts, the cell culture solution was removed separately from the cultures. Afterwards, this solution was mixed with the assay reagent prepared by mixing two separate solutions. This was incubated for 30 minutes, protected from light, and the absorbance was measured at 490 nm with an ELISA reader. 10% triton-X100 was used as the positive control (100% cell lysis). The results were compared with the absorbance values of the triton X-100 (10%) (positive control), which give the maximum activity. The cytotoxicity index was calculated according to the formula below; Cytotoxicity Index (%) = 1 -[(Atreated wells-A negative control) / (Apositive control-Acontrol cells)] x 100
